Skip to main content
. 2017 Jul 5;8(46):80416–80428. doi: 10.18632/oncotarget.19010

Table 1. N° of variations and variation rate (n° of variations/Mb) of responder and non-responder osteosarcoma patients.

Sample N° of variations Variations rate Status
1 1390 118.8 Responder
5 8500 726.5 Responder
6 496 42.4 Responder
7 791 67.6 Responder
8 802 68.5 Responder
2 4211 359.9 Non-Responder
3 1495 127.8 Non-Responder
4 1095 93.6 Non-Responder

We did not find common mutated genes in all eight samples but we found three mutated genes (KIF1B, NEB, KMT2C) in 7/8 (87%) samples. Seventeen genes were mutated in 6 samples (75%, 6/8) and 57 genes showed variations in 5 samples (62.5%, 5/8). We noted a great variability of genes mutated among the samples as shown in Supplementary Table 1. Indeed, taking into consideration common mutated genes in at least 5 samples, we noted that sample n°5 showed variations in 77 genes while the sample n°6 showed variations only in 22 genes (Supplementary Table 1).

These 77 genes that were found mutated in more than half of the samples are involved in important biological processes such as transcription regulation, ion transport, DNA damage and repair, cell adhesion and angiogenesis (Table 2).